Trump Administration Aims To Speed Process For Releasing Migrant Children From Detention Camps To Grandparents, Siblings
Suspending the use of the immigration background checks could speed up the release of children by at least two or three days. About 13,200 children are in custody. Other administration news focuses on the flawed safety approval of the new depression drug esketamine.
Trump Administration Moves To Release Migrant Children Faster From U.S. Custody
The Trump administration is again changing the way it vets people who want to sponsor minors who crossed the U.S.-Mexico border alone in an effort to speed up the release of thousands of migrant children currently in U.S. custody. Under the change, announced to staff on Friday, the U.S. Department of Health and Human Services (HHS), which houses unaccompanied migrant children, will no longer require an immigration records check on potential sponsors already backgrounded by the Federal Bureau of Investigation (FBI). (6/10)
Kaiser Health News:
FDA Overlooked Red Flags In Drugmaker’s Testing Of New Depression Medicine
Ketamine is a darling of combat medics and clubgoers, an anesthetic that can quiet your pain without suppressing breathing and a hallucinogenic that can get you high with little risk of a fatal overdose. For some patients, it also has dwelled in the shadows of conventional medicine as a depression treatment — prescribed by their doctors, but not approved for that purpose by the federal agency responsible for determining which treatments are “safe and effective.” (Huetteman, 6/11)